Sunshine Biopharma (SBFM) Other Non Operating Income (2015 - 2026)

Sunshine Biopharma has reported Other Non Operating Income for 12 years, with the latest figure at -$18.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 103.99% year-over-year to -$18.0; the trailing twelve-month figure through Mar 2026 stood at $2173.0 (up 105.74% YoY), and the FY2025 full-year result was $2642.0, up 105.99% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$18.0, down from -$2.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $286535.0 in Q2 2024, with the low at -$340003.0 in Q4 2024.
• Historically, Other Non Operating Income has averaged -$1177.6 across 5 years, with a median of $25.0 in 2022.
• Annual changes were most pronounced in 2022 — Other Non Operating Income surged 135662.5% — and 2024, when it slumped 871702.56%.
• Sunshine Biopharma's Other Non Operating Income stood at $10807.0 in 2022, then tumbled by 100.36% to -$39.0 in 2023, then tumbled by 871702.56% to -$340003.0 in 2024, then jumped by 100.0% to -$2.0 in 2025, then sank by 800.0% to -$18.0 in 2026.
• The last three Other Non Operating Income figures came in at -$18.0 (Q1 2026), -$2.0 (Q4 2025), and $253.0 (Q3 2025), per Business Quant data.